FAIR VALUE MEASUREMENTS (Details 3) (USD $) | 3 Months Ended |
Mar. 31, 2014 |
Low end of range | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Illiquidity Discount (as a percent) | 5.00% |
Dealer quotes or third party fund managers | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
CLO Debt Obligations | 1,200,000,000 |
Level III | Private Equity Investments | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Fair Value | 30,876,329,000 |
Level III | Private Equity Investments | Health Care | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Fair Value | 7,304,191,000 |
Level III | Private Equity Investments | Technology | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Fair Value | 4,170,652,000 |
Level III | Private Equity Investments | Retail | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Fair Value | 3,982,083,000 |
Level III | Private Equity Investments | Consumer Products | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Fair Value | 3,888,266,000 |
Level III | Private Equity Investments | Financial Services | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Fair Value | 3,378,399,000 |
Level III | Private Equity Investments | Other | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Fair Value | 8,152,738,000 |
Level III | Energy/Infrastructure | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Fair Value | 2,945,623,000 |
Level III | Real Estate | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Fair Value | 835,305,000 |
Level III | Credit | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Fair Value | 2,317,366,000 |
Level III | Other | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Value of investments in real assets whose valuation inputs are not comparable to other private equity investments | 778,600,000 |
Level III | Real Assets | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Fair Value | 3,780,928,000 |
Level III | Market Comparables and Discounted Cash Flows | Private Equity Investments | Weighted Average | Health Care | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Illiquidity Discount (as a percent) | 7.00% |
Weight Ascribed to Market Comparables (as a percent) | 50.00% |
Weight Ascribed to Discounted Cash Flow (as a percent) | 50.00% |
Level III | Market Comparables and Discounted Cash Flows | Private Equity Investments | Weighted Average | Technology | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Illiquidity Discount (as a percent) | 11.00% |
Weight Ascribed to Market Comparables (as a percent) | 50.00% |
Weight Ascribed to Discounted Cash Flow (as a percent) | 50.00% |
Level III | Market Comparables and Discounted Cash Flows | Private Equity Investments | Weighted Average | Retail | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Illiquidity Discount (as a percent) | 8.00% |
Weight Ascribed to Market Comparables (as a percent) | 50.00% |
Weight Ascribed to Discounted Cash Flow (as a percent) | 50.00% |
Level III | Market Comparables and Discounted Cash Flows | Private Equity Investments | Weighted Average | Consumer Products | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Illiquidity Discount (as a percent) | 11.00% |
Weight Ascribed to Market Comparables (as a percent) | 49.00% |
Weight Ascribed to Discounted Cash Flow (as a percent) | 51.00% |
Level III | Market Comparables and Discounted Cash Flows | Private Equity Investments | Weighted Average | Financial Services | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Illiquidity Discount (as a percent) | 10.00% |
Weight Ascribed to Market Comparables (as a percent) | 53.00% |
Weight Ascribed to Discounted Cash Flow (as a percent) | 47.00% |
Level III | Market Comparables and Discounted Cash Flows | Private Equity Investments | Weighted Average | Other | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Illiquidity Discount (as a percent) | 11.00% |
Weight Ascribed to Market Comparables (as a percent) | 47.00% |
Weight Ascribed to Discounted Cash Flow (as a percent) | 53.00% |
Level III | Market Comparables and Discounted Cash Flows | Private Equity Investments | Low end of range | Health Care | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Illiquidity Discount (as a percent) | 5.00% |
Weight Ascribed to Market Comparables (as a percent) | 50.00% |
Weight Ascribed to Discounted Cash Flow (as a percent) | 50.00% |
Level III | Market Comparables and Discounted Cash Flows | Private Equity Investments | Low end of range | Technology | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Illiquidity Discount (as a percent) | 5.00% |
Weight Ascribed to Market Comparables (as a percent) | 50.00% |
Weight Ascribed to Discounted Cash Flow (as a percent) | 50.00% |
Level III | Market Comparables and Discounted Cash Flows | Private Equity Investments | Low end of range | Retail | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Illiquidity Discount (as a percent) | 5.00% |
Weight Ascribed to Market Comparables (as a percent) | 0.00% |
Weight Ascribed to Discounted Cash Flow (as a percent) | 50.00% |
Level III | Market Comparables and Discounted Cash Flows | Private Equity Investments | Low end of range | Consumer Products | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Illiquidity Discount (as a percent) | 10.00% |
Weight Ascribed to Market Comparables (as a percent) | 0.00% |
Weight Ascribed to Discounted Cash Flow (as a percent) | 50.00% |
Level III | Market Comparables and Discounted Cash Flows | Private Equity Investments | Low end of range | Financial Services | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Illiquidity Discount (as a percent) | 10.00% |
Weight Ascribed to Market Comparables (as a percent) | 50.00% |
Weight Ascribed to Discounted Cash Flow (as a percent) | 0.00% |
Level III | Market Comparables and Discounted Cash Flows | Private Equity Investments | Low end of range | Other | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Illiquidity Discount (as a percent) | 10.00% |
Weight Ascribed to Market Comparables (as a percent) | 0.00% |
Weight Ascribed to Discounted Cash Flow (as a percent) | 33.00% |
Level III | Market Comparables and Discounted Cash Flows | Private Equity Investments | High end of range | Health Care | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Illiquidity Discount (as a percent) | 15.00% |
Weight Ascribed to Market Comparables (as a percent) | 50.00% |
Weight Ascribed to Discounted Cash Flow (as a percent) | 50.00% |
Level III | Market Comparables and Discounted Cash Flows | Private Equity Investments | High end of range | Technology | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Illiquidity Discount (as a percent) | 20.00% |
Weight Ascribed to Market Comparables (as a percent) | 50.00% |
Weight Ascribed to Discounted Cash Flow (as a percent) | 50.00% |
Level III | Market Comparables and Discounted Cash Flows | Private Equity Investments | High end of range | Retail | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Illiquidity Discount (as a percent) | 20.00% |
Weight Ascribed to Market Comparables (as a percent) | 50.00% |
Weight Ascribed to Discounted Cash Flow (as a percent) | 100.00% |
Level III | Market Comparables and Discounted Cash Flows | Private Equity Investments | High end of range | Consumer Products | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Illiquidity Discount (as a percent) | 15.00% |
Weight Ascribed to Market Comparables (as a percent) | 50.00% |
Weight Ascribed to Discounted Cash Flow (as a percent) | 100.00% |
Level III | Market Comparables and Discounted Cash Flows | Private Equity Investments | High end of range | Financial Services | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Illiquidity Discount (as a percent) | 15.00% |
Weight Ascribed to Market Comparables (as a percent) | 100.00% |
Weight Ascribed to Discounted Cash Flow (as a percent) | 50.00% |
Level III | Market Comparables and Discounted Cash Flows | Private Equity Investments | High end of range | Other | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Illiquidity Discount (as a percent) | 20.00% |
Weight Ascribed to Market Comparables (as a percent) | 67.00% |
Weight Ascribed to Discounted Cash Flow (as a percent) | 100.00% |
Level III | Market Comparables | Private Equity Investments | Retail | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Enterprise Value / LTM EBITDA Multiple, excluded investment | 22.5 |
Enterprise Value / Forward EBITDA Multiple, excluded investment | 18.7 |
Level III | Market Comparables | Private Equity Investments | Other | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Maximum percentage of investments that utilize some control premium as a percent of the total investments | 5.00% |
Level III | Market Comparables | Private Equity Investments | Weighted Average | Health Care | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Enterprise Value / LTM EBITDA Multiple | 11 |
Enterprise Value / Forward EBITDA Multiple | 10 |
Level III | Market Comparables | Private Equity Investments | Weighted Average | Technology | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Enterprise Value / LTM EBITDA Multiple | 12 |
Enterprise Value / Forward EBITDA Multiple | 11 |
Level III | Market Comparables | Private Equity Investments | Weighted Average | Retail | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Enterprise Value / LTM EBITDA Multiple | 12 |
Enterprise Value / Forward EBITDA Multiple | 10 |
Level III | Market Comparables | Private Equity Investments | Weighted Average | Consumer Products | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Enterprise Value / LTM EBITDA Multiple | 13 |
Enterprise Value / Forward EBITDA Multiple | 12 |
Level III | Market Comparables | Private Equity Investments | Weighted Average | Financial Services | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Enterprise Value / LTM EBITDA Multiple | 12 |
Enterprise Value / Forward EBITDA Multiple | 11 |
Level III | Market Comparables | Private Equity Investments | Weighted Average | Other | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Enterprise Value / LTM EBITDA Multiple | 11 |
Enterprise Value / Forward EBITDA Multiple | 10 |
Control Premium (as a percent) | 3.00% |
Level III | Market Comparables | Private Equity Investments | Low end of range | Health Care | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Enterprise Value / LTM EBITDA Multiple | 10 |
Enterprise Value / Forward EBITDA Multiple | 10 |
Level III | Market Comparables | Private Equity Investments | Low end of range | Technology | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Enterprise Value / LTM EBITDA Multiple | 5 |
Enterprise Value / Forward EBITDA Multiple | 6 |
Level III | Market Comparables | Private Equity Investments | Low end of range | Retail | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Enterprise Value / LTM EBITDA Multiple | 8 |
Enterprise Value / Forward EBITDA Multiple | 7 |
Level III | Market Comparables | Private Equity Investments | Low end of range | Consumer Products | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Enterprise Value / LTM EBITDA Multiple | 8 |
Enterprise Value / Forward EBITDA Multiple | 8 |
Level III | Market Comparables | Private Equity Investments | Low end of range | Financial Services | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Enterprise Value / LTM EBITDA Multiple | 11 |
Enterprise Value / Forward EBITDA Multiple | 10 |
Level III | Market Comparables | Private Equity Investments | Low end of range | Other | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Enterprise Value / LTM EBITDA Multiple | 6 |
Enterprise Value / Forward EBITDA Multiple | 6 |
Control Premium (as a percent) | 0.00% |
Level III | Market Comparables | Private Equity Investments | High end of range | Health Care | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Enterprise Value / LTM EBITDA Multiple | 14 |
Enterprise Value / Forward EBITDA Multiple | 12 |
Level III | Market Comparables | Private Equity Investments | High end of range | Technology | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Enterprise Value / LTM EBITDA Multiple | 14 |
Enterprise Value / Forward EBITDA Multiple | 13 |
Level III | Market Comparables | Private Equity Investments | High end of range | Retail | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Enterprise Value / LTM EBITDA Multiple | 13 |
Enterprise Value / Forward EBITDA Multiple | 11 |
Portfolio company's investments as a percentage of total investments, at fair value | 0.50% |
Level III | Market Comparables | Private Equity Investments | High end of range | Consumer Products | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Enterprise Value / LTM EBITDA Multiple | 18 |
Enterprise Value / Forward EBITDA Multiple | 16 |
Level III | Market Comparables | Private Equity Investments | High end of range | Financial Services | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Enterprise Value / LTM EBITDA Multiple | 13 |
Enterprise Value / Forward EBITDA Multiple | 11 |
Level III | Market Comparables | Private Equity Investments | High end of range | Other | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Enterprise Value / LTM EBITDA Multiple | 17 |
Enterprise Value / Forward EBITDA Multiple | 14 |
Control Premium (as a percent) | 20.00% |
Level III | Direct Income Capitalization And Discounted Cash Flow | Real Estate | Weighted Average | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weight Ascribed to Discounted Cash Flow (as a percent) | 85.00% |
Weight Ascribed to direct income capitalization (as a percent) | 15.00% |
Level III | Direct Income Capitalization And Discounted Cash Flow | Real Estate | Low end of range | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weight Ascribed to Discounted Cash Flow (as a percent) | 0.00% |
Weight Ascribed to direct income capitalization (as a percent) | 0.00% |
Level III | Direct Income Capitalization And Discounted Cash Flow | Real Estate | High end of range | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weight Ascribed to Discounted Cash Flow (as a percent) | 100.00% |
Weight Ascribed to direct income capitalization (as a percent) | 100.00% |
Level III | Discounted Cash Flows | Private Equity Investments | Weighted Average | Health Care | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weighted average cost of capital (as a percent) | 10.00% |
Enterprise Value / Exit Multiple LTM EBITDA | 11 |
Level III | Discounted Cash Flows | Private Equity Investments | Weighted Average | Technology | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weighted average cost of capital (as a percent) | 11.00% |
Enterprise Value / Exit Multiple LTM EBITDA | 9 |
Level III | Discounted Cash Flows | Private Equity Investments | Weighted Average | Retail | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weighted average cost of capital (as a percent) | 11.00% |
Enterprise Value / Exit Multiple LTM EBITDA | 8 |
Level III | Discounted Cash Flows | Private Equity Investments | Weighted Average | Consumer Products | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weighted average cost of capital (as a percent) | 13.00% |
Enterprise Value / Exit Multiple LTM EBITDA | 9 |
Level III | Discounted Cash Flows | Private Equity Investments | Weighted Average | Financial Services | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weighted average cost of capital (as a percent) | 10.00% |
Enterprise Value / Exit Multiple LTM EBITDA | 10 |
Level III | Discounted Cash Flows | Private Equity Investments | Weighted Average | Other | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weighted average cost of capital (as a percent) | 12.00% |
Enterprise Value / Exit Multiple LTM EBITDA | 10 |
Level III | Discounted Cash Flows | Private Equity Investments | Low end of range | Health Care | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weighted average cost of capital (as a percent) | 9.00% |
Enterprise Value / Exit Multiple LTM EBITDA | 9 |
Level III | Discounted Cash Flows | Private Equity Investments | Low end of range | Technology | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weighted average cost of capital (as a percent) | 9.00% |
Enterprise Value / Exit Multiple LTM EBITDA | 6 |
Level III | Discounted Cash Flows | Private Equity Investments | Low end of range | Retail | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weighted average cost of capital (as a percent) | 9.00% |
Enterprise Value / Exit Multiple LTM EBITDA | 6 |
Level III | Discounted Cash Flows | Private Equity Investments | Low end of range | Consumer Products | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weighted average cost of capital (as a percent) | 10.00% |
Enterprise Value / Exit Multiple LTM EBITDA | 6 |
Level III | Discounted Cash Flows | Private Equity Investments | Low end of range | Financial Services | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weighted average cost of capital (as a percent) | 9.00% |
Enterprise Value / Exit Multiple LTM EBITDA | 10 |
Level III | Discounted Cash Flows | Private Equity Investments | Low end of range | Other | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weighted average cost of capital (as a percent) | 9.00% |
Enterprise Value / Exit Multiple LTM EBITDA | 5 |
Level III | Discounted Cash Flows | Private Equity Investments | High end of range | Health Care | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weighted average cost of capital (as a percent) | 13.00% |
Enterprise Value / Exit Multiple LTM EBITDA | 12 |
Level III | Discounted Cash Flows | Private Equity Investments | High end of range | Technology | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weighted average cost of capital (as a percent) | 14.00% |
Enterprise Value / Exit Multiple LTM EBITDA | 11 |
Level III | Discounted Cash Flows | Private Equity Investments | High end of range | Retail | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weighted average cost of capital (as a percent) | 23.00% |
Enterprise Value / Exit Multiple LTM EBITDA | 9 |
Level III | Discounted Cash Flows | Private Equity Investments | High end of range | Consumer Products | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weighted average cost of capital (as a percent) | 26.00% |
Enterprise Value / Exit Multiple LTM EBITDA | 12 |
Level III | Discounted Cash Flows | Private Equity Investments | High end of range | Financial Services | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weighted average cost of capital (as a percent) | 10.00% |
Enterprise Value / Exit Multiple LTM EBITDA | 11 |
Level III | Discounted Cash Flows | Private Equity Investments | High end of range | Other | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weighted average cost of capital (as a percent) | 21.00% |
Enterprise Value / Exit Multiple LTM EBITDA | 12 |
Level III | Discounted Cash Flows | Energy/Infrastructure | Weighted Average | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weighted average cost of capital (as a percent) | 11.00% |
Enterprise Value / Exit Multiple LTM EBITDA | 8 |
Level III | Discounted Cash Flows | Energy/Infrastructure | Low end of range | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weighted average cost of capital (as a percent) | 6.00% |
Enterprise Value / Exit Multiple LTM EBITDA | 7 |
Level III | Discounted Cash Flows | Energy/Infrastructure | High end of range | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Weighted average cost of capital (as a percent) | 19.00% |
Enterprise Value / Exit Multiple LTM EBITDA | 10 |
Level III | Discounted Cash Flows | Real Estate | Weighted Average | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Unlevered Discount Rate (as a percent) | 11.00% |
Level III | Discounted Cash Flows | Real Estate | Low end of range | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Unlevered Discount Rate (as a percent) | 9.00% |
Level III | Discounted Cash Flows | Real Estate | High end of range | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Unlevered Discount Rate (as a percent) | 24.00% |
Level III | Direct income capitalization | Real Estate | Weighted Average | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Current Capitalization Rate (as a percent) | 7.00% |
Level III | Direct income capitalization | Real Estate | Low end of range | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Current Capitalization Rate (as a percent) | 6.00% |
Level III | Direct income capitalization | Real Estate | High end of range | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Current Capitalization Rate (as a percent) | 9.00% |
Level III | Yield analysis | Credit | Weighted Average | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Yield to maturity (as a percent) | 10.00% |
Net Leverage | 5 |
EBITDA Multiple | 9 |
Level III | Yield analysis | Credit | Low end of range | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Yield to maturity (as a percent) | 5.00% |
Net Leverage | 2 |
EBITDA Multiple | 5 |
Level III | Yield analysis | Credit | High end of range | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Yield to maturity (as a percent) | 19.00% |
Net Leverage | 15 |
EBITDA Multiple | 14 |
Level III | Dealer quotes or third party fund managers | Credit | ' |
Level III investments and other financial instruments by valuation methodologies | ' |
Fair Value | 25,900,000 |